Evidence map›Paper›PMID 40462422›Full record

GuidelineZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2025

[Guideline for transfusion management in Chinese children with transfusion-dependent thalassemia (2025)].

Committee of Thalassemia Prevention and Treatment, China Maternal and Child Health Association, Subspecialty Group of Hematology, Society of Pediatrics, Chinese Medical Association, China Thalasemia Prevention and ControlCollaboration Network, Editorial Board of Chinese Journal of Contemporary Pediatrics

Abstract readPractice GuidelineEnglish Abstract
In one paragraph

Guideline in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Committee of Thalassemia Prevention and Treatment, China Maternal and Child Health Association
Subspecialty Group of Hematology, Society of Pediatrics, Chinese Medical Association
China Thalasemia Prevention and ControlCollaboration Network
Editorial Board of Chinese Journal of Contemporary Pediatrics

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thalassemia is a group of hereditary disorders characterized by ineffective erythropoiesis due to hemoglobin synthesis abnormalities, resulting in varying degrees of chronic anemia. Patients with transfusion-dependent thalassemia rely on lifelong regular blood transfusions and iron chelation therapy. Proper transfusion treatment and management of transfusion-related complications are essential to ensure the growth and development of pediatric patients and to improve their quality of life. The guideline working group has developed the guideline by referencing domestic and international guidelines, expert consensus, and relevant studies. The aim is to further standardize the transfusion management of transfusion-dependent thalassemia in children in China.

Indexed as

Blood TransfusionThalassemiaChildEast Asian PeopleHumansBlood transfusionChildGuidelineManagementTransfusion-dependent thalassemia

Identifiers

PMID40462422
PMCPMC12169880

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.